Pages that link to "Q40462947"
Jump to navigation
Jump to search
The following pages link to Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance. (Q40462947):
Displaying 50 items.
- Redox activation of metal-based prodrugs as a strategy for drug delivery (Q27025736) (← links)
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs (Q28066801) (← links)
- Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery (Q33695863) (← links)
- Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCs (Q33761590) (← links)
- Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery (Q33825880) (← links)
- Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs. (Q33850523) (← links)
- Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance. (Q34060461) (← links)
- Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes (Q34731239) (← links)
- Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery (Q35000093) (← links)
- Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance. (Q35334366) (← links)
- Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells (Q35953911) (← links)
- Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties (Q37042860) (← links)
- New trends for metal complexes with anticancer activity (Q37044080) (← links)
- Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position (Q37087045) (← links)
- Novel metals and metal complexes as platforms for cancer therapy (Q37137649) (← links)
- Monofunctional and higher-valent platinum anticancer agents. (Q37282213) (← links)
- Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. (Q37603642) (← links)
- Synthetic methods for the preparation of platinum anticancer complexes (Q37722632) (← links)
- Tuning heavy metal compounds for anti-tumor activity: is diversity the key to ruthenium's success? (Q37855894) (← links)
- Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules (Q38034439) (← links)
- Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends (Q38052406) (← links)
- Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs (Q38105454) (← links)
- Metal complex interactions with DNA. (Q38271731) (← links)
- A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines. (Q38696069) (← links)
- Platinum-based drugs: past, present and future (Q38737115) (← links)
- Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy (Q38762779) (← links)
- Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity. (Q38823861) (← links)
- Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy (Q38848959) (← links)
- Oxaliplatin analogues with carboxy derivatives of boldine with enhanced antioxidant activity (Q38894400) (← links)
- Antitumor properties of platinum(iv) prodrug-loaded silk fibroin nanoparticles. (Q38896341) (← links)
- The Platin-X series: activation, targeting, and delivery. (Q38919253) (← links)
- Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery. (Q39196999) (← links)
- A polymer-(tandem drugs) conjugate for enhanced cancer treatment (Q39214856) (← links)
- Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator. (Q39229225) (← links)
- Nitric oxide donor-based platinum complexes as potential anticancer agents. (Q39270724) (← links)
- Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity (Q39278942) (← links)
- Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs. (Q39298980) (← links)
- Comparative analyses of cytotoxicity and molecular mechanisms between platinum metallointercalators and cisplatin (Q39311584) (← links)
- Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferase (Q39967654) (← links)
- In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo. (Q39971078) (← links)
- Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin. (Q41212195) (← links)
- A fluorescent probe for investigating the activation of anticancer platinum(IV) prodrugs based on the cisplatin scaffold. (Q44320923) (← links)
- Novel organometallic cationic ruthenium(II) pentamethylcyclopentadienyl benzenesulfonamide complexes targeted to inhibit carbonic anhydrase (Q44649427) (← links)
- Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions (Q44653144) (← links)
- Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design (Q44679743) (← links)
- Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models (Q46417081) (← links)
- Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs (Q46964649) (← links)
- Platinum(iv) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells. (Q47717480) (← links)
- Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cells (Q47766629) (← links)
- Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery (Q50803523) (← links)